MedPacto Hires Global Clinical Expert Timothy R. Allen as Executive Vice President
SEOUL, South Korea--(BUSINESS WIRE)--#AntiCancerDrug--MedPacto, Inc. (KOSDAQ: 235980), a genome-based drug discovery and clinical-stage biotechnology company, is accelerating its global clinical...






